Novel luminescence assay offers new possibilities for the risk assessment of silica nanoparticles

References

• Ahlin P, Kristl J, Kristl A, Vrecer F. Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. Int J Pharm 2002; 239(1–2)113–120
   PubMedGoogle Scholar
• Allemann E, Leroux J, Gurny R. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Deliv Rev 1998; 34(2–3)171–189
   PubMed Web of Science ®Google Scholar
• Artursson P, Borchardt RT. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm Res 1997; 14(12)1655–1658
   PubMed Web of Science ®Google Scholar
• Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 2001; 46(1–3)27–43
   PubMed Web of Science ®Google Scholar
• Balamurugan B, Toshiro M. Inhomogeneous effect of particle size on core-level and valence-band electrons: Size-dependent electronic structure of Cu[sub 3]N nanoparticles. Applied Physics Letters 2006; 89(3)033112–3
   Web of Science ®Google Scholar
• Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24(2–3)119–124
   PubMed Web of Science ®Google Scholar
• Chiu IS. A study of the size effect on the temperature-dependent resistivity of bismuth nanowires with rectangular cross-sections. Nanotechnology 2004; 15: 1489–1492
   Web of Science ®Google Scholar
• Chong HS, Garmestani K, Bryant LH, Jr, Milenic DE, Overstreet T, Birch N, Le T, Brady ED, Brechbiel MW. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging. J Med Chem 2006; 49(6)2055–2062
   PubMed Web of Science ®Google Scholar
• Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, Huang DM. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 2007; 28(19)2959–2966
   PubMed Web of Science ®Google Scholar
• Crouch SP. Biocompatibility testing using ATP bioluminescence. Med Device Technol 2000; 11(8)12–15
   PubMedGoogle Scholar
• Crouch SP, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 1993; 160(1)81–88
   PubMed Web of Science ®Google Scholar
• Evonik. 2007. Aerosil(R) 200 hydrophilic fumed silica.
   Google Scholar
• Evonik. 2008. Aerosil(R) 200 safety data sheet.
   Google Scholar
• Fogh J, Fogh JM, Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 1977; 59(1)221–226
   PubMed Web of Science ®Google Scholar
• Frgala T, Kalous O, Proffitt RT, Reynolds CP. A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations. Mol Cancer Ther 2007; 6(3)886–897
   PubMed Web of Science ®Google Scholar
• Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 1982; 218(4571)474–475
   PubMed Web of Science ®Google Scholar
• Hansen SF, Michelson ES, Kamper A, Borling P, Stuer-Lauridsen F, Baun A. Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 2008; 17(5)438–447
   PubMed Web of Science ®Google Scholar
• Heikkila T, Salonen J, Tuura J, Hamdy MS, Mul G, Kumar N, Salmi T, Murzin DY, Laitinen L, Kaukonen AM, et al. Mesoporous silica material TUD-1 as a drug delivery system. Int J Pharm 2007a; 331(1)133–138
   PubMed Web of Science ®Google Scholar
• Heikkila T, Salonen J, Tuura J, Kumar N, Salmi T, Murzin DY, Hamdy MS, Mul G, Laitinen L, Kaukonen AM, et al. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Drug Deliv 2007b; 14(6)337–347
   PubMed Web of Science ®Google Scholar
• Herzog E, Casey A, Lyng FM, Chambers G, Byrne HJ, Davoren M. A new approach to the toxicity testing of carbon-based nanomaterials – the clonogenic assay. Toxicol Lett 2007; 174(1–3)49–60
   PubMed Web of Science ®Google Scholar
• Ito A, Shinkai M, Honda H, Kobayashi T. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 2005; 100(1)1–11
   PubMed Web of Science ®Google Scholar
• Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker JR, Jr. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 2005; 65(12)5317–5324
   PubMed Web of Science ®Google Scholar
• Laaksonen T, Santos H, Vihola H, Salonen J, Riikonen J, Heikkila T, Peltonen L, Kumar N, Murzin DY, Lehto VP, et al. Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles. Chem Res Toxicol. 2007; 20(12)1913–8
   PubMed Web of Science ®Google Scholar
• Malich G, Markovic B, Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 1997; 124(3)179–192
   PubMed Web of Science ®Google Scholar
• Maynard AD. Nanotechnology: The next big thing, or much ado about nothing?. Ann Occup Hyg 2007; 51(1)1–12
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65(1–2)55–63
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006; 311(5761)622–627
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part Fibre Toxicol 2005a; 2: 8
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005b; 113(7)823–839
   PubMed Web of Science ®Google Scholar
• Salonen J, Laitinen L, Kaukonen AM, Tuura J, Bjorkqvist M, Heikkila T, Vaha-Heikkila K, Hirvonen J, Lehto VP. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J Control Release 2005; 108(2–3)362–374
   PubMed Web of Science ®Google Scholar
• Scientific Committee on Consumer Products (SCCP), European Commission. 2007. SCCP SCoCP. Safety of nanomaterials on cosmetic products. 18 December 2007.
   Google Scholar
• Schulze C, Kroll A, Lehr C-M, Schäfer UF, Becker K, Schnekenburger J, Schulze Isfort C, Landsiedel R, Wohlleben W. Not ready to use – overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2008; 2(2)51–61
   Web of Science ®Google Scholar
• Ulukaya E, Ozdikicioglu F, Oral AY, Demirci M. The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested. Toxicol In Vitro 2008; 22(1)232–239
   PubMed Web of Science ®Google Scholar
• Wang Z, Li J, Liu B, Hu J, Yao X, Li J. Chemiluminescence of CdTe nanocrystals induced by direct chemical oxidation and its size-dependent and surfactant-sensitized effect. J Phys Chem B 2005; 109(49)23304–23311
   PubMed Web of Science ®Google Scholar
• Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm 2005; 288(2)369–376
   PubMed Web of Science ®Google Scholar
• Worle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 2006; 6(6)1261–1268
   PubMed Web of Science ®Google Scholar